查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1617732

高通量筛检市场：按产品和服务、筛检规模、技术、应用、最终用户 - 2025-2030 年全球预测

High-Throughput Screening Market by Product & Service (Consumables, Instruments, Services), Screening Size (12-well Format, 1536-well Format, 24-well Format), Technology, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年高通量筛检市场价值为242亿美元，预计2024年将达270.1亿美元，复合年增长率为12.08%，到2030年将达到537.8亿美元。

高通量筛检(HTS) 是药物发现和化学生物学中的重要技术，有助于在细胞或分子层面上快速检测数千至数百万个样本的生物活性。 HTS 主要用于识别调节特定生物分子途径的活性化合物、抗体或基因。对 HTS 的需求源于对高效药物发现过程日益增长的需求，使研究人员能够从庞大的化学和遗传材料库中快速识别有前途的候选化合物。 HTS的应用广泛，包括製药、生物技术和学术研究机构，为药物开发商、生物科学家和基因组研究人员等最终用户提供服务。市场成长受到机器人和资料分析技术进步以及对个人化医疗和生技药品日益增长的兴趣的显着影响。一个关键的机会在于越来越多地使用人工智慧和机器学习来增强 HTS 的资料分析能力，从而提高预测准确性并减少误报。此外，检测小型化和自动化的进步为降低成本和提高通量开闢了进一步的途径。然而，高温超导技术所需的高初始投资以及与资料管理和整合相关的复杂性等挑战可能会限制市场成长。智慧财产权问题和监管障碍也是主要障碍。专注于生物资讯学和高温超导整合的创新以及新型检测技术的开发，特别是在基因组学和蛋白​​质组学领域，为业务成长提供了肥沃的土壤。在持续技术进步的推动下，市场预计将充满活力和竞争。希望获得市场占有率的公司可以透过投资强大的资料分析工具并专注于合作伙伴关係关係来简化 HTS 方法，从而在不断发展的药物发现和个人化医疗领域中保持领先地位。

主要市场统计
基准年[2023] 242亿美元
预测年份 [2024] 270.1亿美元
预测年份 [2030] 537.8亿美元
复合年增长率（%） 12.08%

市场动态：揭示快速发展的高通量筛检市场的关键市场洞察

高通量筛检市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 生技和製药公司更采用开放式创新模式
    • 增加干细胞研究中的应用
  • 市场限制因素
    • 设备采购维护高成本
  • 市场机会
    • 製药公司及政府部门加大研发投入
    • 高通量筛检技术的进展
  • 市场挑战
    • 缺乏熟练的操作员和资料解释的复杂性

波特五力：驾驭高通量筛检市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解高通量筛检市场的外部影响

外部宏观环境因素在塑造高通量筛检市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解高通量筛检市场的竞争格局

高通量筛检市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵高通量筛检市场供应商绩效评估

FPNV定位矩阵是评估高通量筛检市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了高通量筛检市场的成功之路

高通量筛检市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大生技和製药公司采用开放式创新模式
      • 增加干细胞研究中的应用
    • 抑制因素
      • 设备采购及维护成本高
    • 机会
      • 製药业及政府部门加大研发投入
      • 高通量筛检技术的进步
    • 任务
      • 缺乏熟练的操作员和资料解释的复杂性
  • 市场区隔分析
    • 产品和服务：在 HTS 流程中使用软体来管理大量原始资料正在蓬勃发展
    • 技术：采用基于细胞的检测技术来获取药物发现过程的生物学相关资料
    • 筛检规模：利用96孔盘格式增加以细胞为基础的研究
    • 应用：高温超导过程在药物发现中广泛使用，以鑑定具有药理或生物活性的化合物
    • 最终用户：透过 HTS 技术在製药和生物技术公司中的渗透，新疗法的快速开发
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章高通量筛检市场：依产品与服务分类

  • 消耗品
    • 实验设备
    • 试剂和检测试剂套件
  • 装置
    • 检测系统
    • 液体处理系统
  • 服务
  • 软体

第七章依筛检尺寸分類的高通量筛检市场

  • 12孔格式
  • 1536孔格式
  • 24孔格式
  • 384孔格式
  • 48孔格式
  • 6孔格式
  • 96孔盘格式

第八章高通量筛检市场：依技术分类

  • 基于细胞的检测
    • 二维细胞培养
    • 3D细胞培养
      • 基于支架的技术
      • 水凝胶
      • 海藻酸盐和琼脂糖
      • 动物源性水凝胶
      • 胶原蛋白
      • 基质胶
      • 合成水凝胶
      • 惰性基质和固体支架
      • 微图案表面
      • 无支架技术
      • 吊挂式滴板
      • 超低结合板
    • 灌流细胞培养
    • 基于报告基因的检测
  • 实验室晶片技术
  • 无标定技术

第九章高通量筛检市场：依应用分类

  • 生化筛检
  • 药物发现
  • 生命科学研究

第 10 章 高通量筛检市场：依最终使用者分类

  • 学术研究所
  • 合约调查机构
  • 製药和生物技术公司

第十一章美洲高通量筛检市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区高通量筛检市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东和非洲高通量筛检市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Axxam 和 Promega 同意开发用于药物发现服务的智慧检测方法
    • Charles River Laboratories 收购 SAMDI Tech
    • Particle Works 发布 ALiS，这是一个用于 LNP 配方筛检的自动化高通量平台
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Aurora Biomed, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomat Srl
  • BMG Labtech GmbH
  • BRAND GMBH+CO KG
  • Charles River Laboratories
  • Corning Incorporated
  • Creative Biolabs, Inc.
  • Danaher Corporation
  • DIANA Biotechnologies, AS
  • Eppendorf SE
  • Eurofins Scientific
  • Gilson Incorporated
  • Hamilton Company
  • HighRes Biosolutions
  • Lonza Group AG
  • Merck KGaA
  • Mettler Toledo International, Inc.
  • PerkinElmer, Inc.
  • Revvity, Inc.
  • Sartorius AG
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Product Code: MRR-501246436FA8

The High-Throughput Screening Market was valued at USD 24.20 billion in 2023, expected to reach USD 27.01 billion in 2024, and is projected to grow at a CAGR of 12.08%, to USD 53.78 billion by 2030.

High-Throughput Screening (HTS) is an essential technology in drug discovery and chemical biology that facilitates the rapid testing of thousands to millions of samples for biological activity at a cellular or molecular level. It is primarily used to identify active compounds, antibodies, or genes that modulate a particular biomolecular pathway. The necessity of HTS arises from the increasing demand for efficient drug discovery processes, allowing researchers to quickly identify promising candidates from massive libraries of chemicals and genetic material. HTS finds applications across pharmaceuticals, biotechnology, and academic research institutions, serving end-users like drug developers, biological scientists, and genomic researchers. Market growth is significantly influenced by technological advancements in robotics and data analytics, alongside an increasing focus on personalized medicine and biologics. Key opportunities lie in the growing use of artificial intelligence and machine learning to enhance the data analysis capabilities of HTS, thereby improving predictive accuracy and reducing false positives. Moreover, the miniaturization of assays and increasing automation open further avenues for cost reduction and increased throughput. However, challenges such as the high initial investment required for HTS technology, and the complexity associated with data management and integration, may restrict market growth. Intellectual property issues and regulatory hurdles also present significant barriers. Innovations focusing on integrating bioinformatics with HTS and developing novel assay techniques, particularly in the field of genomics and proteomics, offer fertile ground for business growth. The market is poised to be dynamic and competitive, driven by continual technological advancements. Firms aiming to capture market share should invest in robust data analytics tools and focus on collaborative partnerships to streamline HTS methodologies, ensuring they remain at the forefront in the evolving landscape of drug discovery and personalized medicine.

KEY MARKET STATISTICS
Base Year [2023] USD 24.20 billion
Estimated Year [2024] USD 27.01 billion
Forecast Year [2030] USD 53.78 billion
CAGR (%) 12.08%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving High-Throughput Screening Market

The High-Throughput Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing adoption of open innovation models in biotechnology and pharmaceutical companies
    • Rising applications in stem cell research
  • Market Restraints
    • High cost associated with the equipment procurement and maintenance
  • Market Opportunities
    • Increasing investment in R&D by pharmaceutical & Government authorities
    • Technological advancements high throughput screening
  • Market Challenges
    • Dearth of skilled operators coupled with complexities related to data interpretation

Porter's Five Forces: A Strategic Tool for Navigating the High-Throughput Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the High-Throughput Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the High-Throughput Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the High-Throughput Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the High-Throughput Screening Market

A detailed market share analysis in the High-Throughput Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the High-Throughput Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the High-Throughput Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the High-Throughput Screening Market

A strategic analysis of the High-Throughput Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the High-Throughput Screening Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Aurora Biomed, Inc., Bio-Rad Laboratories, Inc., Biomat S.r.l, BMG Labtech GmbH, BRAND GMBH + CO KG, Charles River Laboratories, Corning Incorporated, Creative Biolabs, Inc., Danaher Corporation, DIANA Biotechnologies, A.S., Eppendorf SE, Eurofins Scientific, Gilson Incorporated, Hamilton Company, HighRes Biosolutions, Lonza Group AG, Merck KGaA, Mettler Toledo International, Inc., PerkinElmer, Inc., Revvity, Inc., Sartorius AG, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the High-Throughput Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Consumables, Instruments, Services, and Software. The Consumables is further studied across Laboratory Equipment and Reagents & Assay Kits. The Instruments is further studied across Detection Systems and Liquid Handling Systems.
  • Based on Screening Size, market is studied across 12-well Format, 1536-well Format, 24-well Format, 384-well Format, 48-well Format, 6-well Format, and 96-well Format.
  • Based on Technology, market is studied across Cell-Based Assays, Lab-on-a-Chip Technology, and Label-Free Technology. The Cell-Based Assays is further studied across 2D Cell Culture, 3D Cell Culture, Perfusion Cell Culture, and Reporter-Based Assays. The 3D Cell Culture is further studied across Scaffold-Based Technology and Scaffold-Free Technology. The Scaffold-Based Technology is further studied across Hydrogels, Inert Matrix & Solid Scaffolds, and Micropatterned Surfaces. The Hydrogels is further studied across Alginate & Agarose, Animal-Derived Hydrogels, and Synthetic Hydrogels. The Animal-Derived Hydrogels is further studied across Collagen and Matrigel. The Scaffold-Free Technology is further studied across Hanging-Drop Plates and Ultra-Low Binding Plates.
  • Based on Application, market is studied across Biochemical Screening, Drug Discovery, and Life Sciences Research.
  • Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of open innovation models in biotechnology and pharmaceutical companies
      • 5.1.1.2. Rising applications in stem cell research
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the equipment procurement and maintenance
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in R&D by pharmaceutical & Government authorities
      • 5.1.3.2. Technological advancements high throughput screening
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled operators coupled with complexities related to data interpretation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product & Service: Proliferating use of software in the HTS process to manage vast amounts of raw data
    • 5.2.2. Technology: Adoption of cell-based assay technologies to get biologically relevant data for the drug discovery process
    • 5.2.3. Screening Size: Utilization of 96-well format for increase in cell based studies
    • 5.2.4. Application: Extensive utilization of the HTS process in drug discovery to identify compounds with pharmacological or biological activity
    • 5.2.5. End User: Penetration of HTS technology in pharmaceutical & biotechnology companies for rapid development of novel therapeutics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. High-Throughput Screening Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Laboratory Equipment
    • 6.2.2. Reagents & Assay Kits
  • 6.3. Instruments
    • 6.3.1. Detection Systems
    • 6.3.2. Liquid Handling Systems
  • 6.4. Services
  • 6.5. Software

7. High-Throughput Screening Market, by Screening Size

  • 7.1. Introduction
  • 7.2. 12-well Format
  • 7.3. 1536-well Format
  • 7.4. 24-well Format
  • 7.5. 384-well Format
  • 7.6. 48-well Format
  • 7.7. 6-well Format
  • 7.8. 96-well Format

8. High-Throughput Screening Market, by Technology

  • 8.1. Introduction
  • 8.2. Cell-Based Assays
    • 8.2.1. 2D Cell Culture
    • 8.2.2. 3D Cell Culture
      • 8.2.2.1. Scaffold-Based Technology
      • 8.2.2.1.1. Hydrogels
      • 8.2.2.1.1.1. Alginate & Agarose
      • 8.2.2.1.1.2. Animal-Derived Hydrogels
      • 8.2.2.1.1.2.1. Collagen
      • 8.2.2.1.1.2.2. Matrigel
      • 8.2.2.1.1.3. Synthetic Hydrogels
      • 8.2.2.1.2. Inert Matrix & Solid Scaffolds
      • 8.2.2.1.3. Micropatterned Surfaces
      • 8.2.2.2. Scaffold-Free Technology
      • 8.2.2.2.1. Hanging-Drop Plates
      • 8.2.2.2.2. Ultra-Low Binding Plates
    • 8.2.3. Perfusion Cell Culture
    • 8.2.4. Reporter-Based Assays
  • 8.3. Lab-on-a-Chip Technology
  • 8.4. Label-Free Technology

9. High-Throughput Screening Market, by Application

  • 9.1. Introduction
  • 9.2. Biochemical Screening
  • 9.3. Drug Discovery
  • 9.4. Life Sciences Research

10. High-Throughput Screening Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas High-Throughput Screening Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific High-Throughput Screening Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa High-Throughput Screening Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Axxam And Promega Announce Agreement To Develop Smart Assays For Drug Discovery Services
    • 14.3.2. Charles River Laboratories Acquires SAMDI Tech
    • 14.3.3. Particle Works Launches ALiS - An Automated and High-Throughput Platform for LNP Formulation Screening
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Aurora Biomed, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biomat S.r.l
  • 5. BMG Labtech GmbH
  • 6. BRAND GMBH + CO KG
  • 7. Charles River Laboratories
  • 8. Corning Incorporated
  • 9. Creative Biolabs, Inc.
  • 10. Danaher Corporation
  • 11. DIANA Biotechnologies, A.S.
  • 12. Eppendorf SE
  • 13. Eurofins Scientific
  • 14. Gilson Incorporated
  • 15. Hamilton Company
  • 16. HighRes Biosolutions
  • 17. Lonza Group AG
  • 18. Merck KGaA
  • 19. Mettler Toledo International, Inc.
  • 20. PerkinElmer, Inc.
  • 21. Revvity, Inc.
  • 22. Sartorius AG
  • 23. Tecan Group Ltd.
  • 24. Thermo Fisher Scientific Inc.
  • 25. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. HIGH-THROUGHPUT SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. HIGH-THROUGHPUT SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. HIGH-THROUGHPUT SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. HIGH-THROUGHPUT SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HIGH-THROUGHPUT SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HIGH-THROUGHPUT SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 12-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 24-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 48-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 6-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 2D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ALGINATE & AGAROSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MATRIGEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SYNTHETIC HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INERT MATRIX & SOLID SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROPATTERNED SURFACES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HANGING-DROP PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ULTRA-LOW BINDING PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PERFUSION CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY BIOCHEMICAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIFE SCIENCES RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 182. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 236. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 238. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 248. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 249. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 250. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 251. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 252. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 260. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 262. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 264. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 265. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 266. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 272. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 273. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 274. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 275. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 277. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 278. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 280. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 285. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 287. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 288. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 289. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 290. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 291. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 292. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 293. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 294. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 298. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 299. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 300. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 301. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 303. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 304. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 306. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 307. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 308. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)